The purpose of this new drug is to completely cure diabetes. Current treatments primarily focus on balancing blood sugar levels, but do not entirely cure diabetes itself.
KIYAN Group and Collaborating Research Institutions
Biozipcode, Inc.
We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).
Learn More About Us
Contact Us
Biozipcode, Inc.
TEL:
+81-50-5534-7865
E-MAIL:
info@biozipcode.com
ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121
© Copyright 2024 Biozipcode, Inc. All Rights Reserved.